The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 05, 2011
Filed:
Oct. 24, 2006
Gregory Shutske, Pittstown, NJ (US);
Keith J. Harris, Chester, NJ (US);
Kenneth J. Bordeau, Kintnersville, PA (US);
Michael R. Angelastro, Bridgewater, NJ (US);
Stanly John, Bridgewater, NJ (US);
Joseph T. Klein, Neshanic Station, NJ (US);
Jinqi LU, Green Brook, NJ (US);
Catherine Bomont, Bridgewater, NJ (US);
Gregory Shutske, Pittstown, NJ (US);
Keith J. Harris, Chester, NJ (US);
Kenneth J. Bordeau, Kintnersville, PA (US);
Michael R. Angelastro, Bridgewater, NJ (US);
Stanly John, Bridgewater, NJ (US);
Joseph T. Klein, Neshanic Station, NJ (US);
Jinqi Lu, Green Brook, NJ (US);
Catherine Bomont, Bridgewater, NJ (US);
Aventis Pharmaceuticals Inc., Bridgewater, NJ (US);
Abstract
The present invention provides compounds of formula I: a stereoisomer or a pharmaceutically acceptable salt thereof, wherein the variables R, R, R, R, X and n are defined as defined herein. Additionally, a method for treating dopamine-related neurological disorders selected form the group consisting of neurological, psychological, cardiovascular, cognitive or attention disorders, substance abuse and addictive behavior, or a combination thereof, comprising administering to a patient in need of such treatment a therapeutically effective amount of compounds of formula I.